Patient & Real-World Insights
PATIENT-CENTERED INSIGHTS FOR LIFE SCIENCESUnderstanding how patients and caregivers experience disease, treatment pathways, and healthcare systems is essential for developing meaningful therapies, improving patient outcomes, and supporting evidence-based healthcare decisions. MadeAi’s Patient & Real-World Insights services combine AI-enabled analytics with expert research methodologies to help life sciences organizations uncover authentic patient perspectives across real-world data sources.
By analyzing patient conversations, lived experiences, and caregiver perspectives, MadeAi helps pharmaceutical and biotech teams better understand treatment journeys, unmet needs, and the real-world impact of disease—supporting more patient-centered research, development, and engagement strategies.
AI-Powered Patient Insights
60%
Faster Screening & Extraction
50-60%
Operational Cost Savings
>99%
SME + AI Accuracy
100%
Scalable & Repeatable Success
Unlock Patient & Real-World Insights with AI-Driven Research
Our platform and expert services support multiple methodologies designed to capture and analyze real-world patient perspectives, including:
Patients increasingly share their healthcare experiences through online communities, forums, and social platforms. Healthcare Social Media Listening services enable organizations to analyze these conversations to understand how patients discuss symptoms, treatments, side effects, and quality-of-life impacts.
MadeAi applies AI-powered natural language processing to analyze large volumes of patient conversations across digital platforms while identifying emerging themes, treatment perceptions, and evolving patient concerns.
Social media listening is commonly used for:
- Identifying emerging patient concerns and unmet needs
- Understanding real-world treatment experiences
- Monitoring patient sentiment and therapy perception
- Detecting trends in disease discussions and support communities
Patient journey mapping analyzes the full pathway patients take from symptom onset through diagnosis, treatment decisions, and long-term disease management.
MadeAi helps life sciences teams map real-world treatment pathways by combining patient-reported insights, social listening data, and scientific evidence to identify critical decision points and barriers to care.
Patient journey mapping is commonly used for:
- Understanding diagnostic delays and care pathways
- Identifying barriers to treatment access or adherence
- Improving patient engagement strategies
- Supporting patient-centered drug development
Understanding the physical, emotional, and financial burden of disease is critical for demonstrating therapeutic value and identifying opportunities for innovation.
MadeAi analyzes patient narratives, real-world experiences, and caregiver feedback to identify areas where current treatments may fall short or where patient needs remain underserved.
Patient burden and unmet need analyses are commonly used for:
- Supporting value demonstration and evidence generation
- Identifying gaps in current treatment options
- Informing clinical development priorities
- Strengthening patient-centered research initiatives
Caregivers often play a critical role in disease management and treatment decision-making, particularly for chronic or complex conditions. Understanding caregiver perspectives provides a more complete picture of real-world disease impact.
MadeAi combines qualitative research methods with AI-assisted analysis to capture caregiver experiences, challenges, and unmet needs.
Caregiver insights research is commonly used for:
- Understanding caregiver burden and support needs
- Improving patient support programs
- Informing treatment access strategies
- Identifying opportunities for caregiver engagement
Tailored Stakeholder Reports
Our team delivers literature reviews tailored to the specific needs of regulatory, market access, clinical, and scientific stakeholders.
Health Technology Assessment & Market Access:
HTA submissions (e.g., NICE, IQWiG), Global Value Dossiers (GVD), AMCP dossiers, and payer evidence packages.
Clinical & Evidence Strategy:
Disease Area Reports (DAR), epidemiology studies, treatment landscape analysis, and comparator evaluations.
Scientific Publications & Medical Communications:
Peer-reviewed manuscripts and scientific narratives.
Regulatory & Compliance:
Clinical Evaluation Reports (CER), 510(k)/PMA submissions, PSURs, PMCF, and safety documentation
Human Expertise, Enhanced by AI
Our literature review team combines therapeutic knowledge, regulatory experience, and AI expertise to deliver high-quality, reliable outputs.
Therapeutic Area Experts
Deep clinical expertise across a wide range of therapeutic areas, including but not limited to oncology, rare diseases, CNS, cardiovascular, and immunology.
Regulatory & Market Access
Seasoned specialists with hands-on HTA submission experience across NICE, EMA, FDA, and global payer bodies.
AI-Skilled Domain Specialists
Subject matter experts skilled in AI workflows, combining human judgment with AI efficiency.
MD, PhD & PharmD Professionals
Credentialed clinicians and pharmacologists ensuring clinical validity and scientific rigor at every stage.
Cross-functional Collaboration
Integrated expertise across clinical, regulatory, and commercial functions to ensure evidence is aligned, relevant, and decision-ready.
Case Studies & Scientific Research
See what our products can do for you
Book a demo today to see how our Evidence Synthesis and Literature Review Services can transform your workflows and drive success. Our experts are ready to support to your unique evidence synthesis needs—schedule your personalized demo now!
FAQ
MadeAi Patient & Real-World Insights Services combine AI analytics with expert research methodologies to gather authentic patient and caregiver perspectives from real-world data sources. The services support patient-centered drug development, value demonstration, and engagement strategies in pharmaceutical and biotech organizations.
MadeAi applies AI-powered natural language processing to analyze large volumes of patient conversations across forums and social platforms. It identifies emerging unmet needs, treatment perceptions, side effects, and sentiment trends with full traceability.
AI-driven patient journey mapping reveals diagnostic delays, treatment barriers, adherence issues, and critical decision points. Life sciences teams use these insights to improve patient engagement, support programs, and patient-centered clinical development.
MadeAi analyzes patient narratives and caregiver feedback to quantify the physical, emotional, and financial burden of disease. The resulting insights strengthen value dossiers, identify opportunities for innovation, and support evidence generation for Pricing and Reimbursement.
Caregiver research provides a complete picture of disease impact, especially in chronic conditions. MadeAi’s AI-assisted caregiver insights help design better support programs and strengthen patient-centered value stories for HTA and payers.
MadeAi combines AI-analyzed patient conversations with clinical literature and Real-World Evidence (RWE) to create comprehensive patient journey maps and burden analyses. The hybrid approach delivers actionable, evidence-based insights with scientific rigor.
Key use cases include identifying unmet needs, mapping treatment pathways, quantifying disease burden, informing clinical development priorities, and strengthening patient engagement strategies for HEOR, Medical Affairs, and Pharmaceutical Market Access teams.
MadeAi pairs AI natural language processing with expert qualitative research methods and human validation. Every insight is traceable and integrated with peer-reviewed evidence, meeting the standards required for regulatory and payer submissions.